Griffin Serves as Exclusive Financial Advisor to MedAvante

MedAvante provides sophisticated clinical trial services to address the pharmaceutical industry’s need for more accurate results for clinical trials involving central nervous system drugs and, thereby, to reduce cost and the time to market for such drugs

Griffin raised equity capital for the company to fund operations and research and development including: (i) facility expansion; (ii) expand and strengthen the management team; and (iii) upgrade the company’s technological capabilities